235 related articles for article (PubMed ID: 25835498)
21. Positive correlation of tissue inhibitor of metalloproteinase-3 and death-associated protein kinase hypermethylation in head and neck squamous cell carcinoma.
Nayak CS; Carvalho AL; Jeronimo C; Henrique R; Kim MM; Hoque MO; Chang S; Jiang WW; Koch W; Westra W; Sidransky D; Califano J
Laryngoscope; 2007 Aug; 117(8):1376-80. PubMed ID: 17592394
[TBL] [Abstract][Full Text] [Related]
22. DLEC1 is not silenced solely by promoter methylation in head and neck squamous cell carcinoma.
Seven D; Yavuz E; Kilic E; Baltaci E; Karaman E; Ulutin T; Buyru N
Gene; 2015 May; 563(1):83-6. PubMed ID: 25746324
[TBL] [Abstract][Full Text] [Related]
23. Association between RASSF1A promoter methylation and ovarian cancer: a meta-analysis.
Shi H; Li Y; Wang X; Lu C; Yang L; Gu C; Xiong J; Huang Y; Wang S; Lu M
PLoS One; 2013; 8(10):e76787. PubMed ID: 24116157
[TBL] [Abstract][Full Text] [Related]
24. Association of FANCC and PTCH1 with the development of early dysplastic lesions of the head and neck.
Ghosh A; Ghosh S; Maiti GP; Mukherjee S; Mukherjee N; Chakraborty J; Roy A; Roychoudhury S; Panda CK
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S528-38. PubMed ID: 21861228
[TBL] [Abstract][Full Text] [Related]
25. LKB1 downregulation may be independent of promoter methylation or FOXO3 expression in head and neck cancer.
Ekizoglu S; Dalay N; Karaman E; Akdeniz D; Ozaydin A; Buyru N
Transl Res; 2013 Aug; 162(2):122-9. PubMed ID: 23810581
[TBL] [Abstract][Full Text] [Related]
26. Up-regulation of expression and lack of 5' CpG island hypermethylation of p16 INK4a in HPV-positive cervical carcinomas.
Ivanova TA; Golovina DA; Zavalishina LE; Volgareva GM; Katargin AN; Andreeva YY; Frank GA; Kisseljov FL; Kisseljova NP
BMC Cancer; 2007 Mar; 7():47. PubMed ID: 17359536
[TBL] [Abstract][Full Text] [Related]
27. Analysis of promoter hypermethylation of death-associated protein kinase and p16 tumor suppressor genes in actinic keratoses and squamous cell carcinomas of the skin.
Tyler LN; Ai L; Zuo C; Fan CY; Smoller BR
Mod Pathol; 2003 Jul; 16(7):660-4. PubMed ID: 12861061
[TBL] [Abstract][Full Text] [Related]
28. Inactivation of p16INK4a in primary tumors and cell lines of head and neck squamous cell carcinoma.
Kim HS; Chung WB; Hong SH; Kim JA; Na SY; Jang HJ; Sohn YK; Kim JW
Mol Cells; 2000 Oct; 10(5):557-65. PubMed ID: 11101148
[TBL] [Abstract][Full Text] [Related]
29. The Notch signaling pathway in head and neck squamous cell carcinoma: A meta-analysis.
Zhao YY; Yu GT; Xiao T; Hu J
Adv Clin Exp Med; 2017 Aug; 26(5):881-887. PubMed ID: 29068587
[TBL] [Abstract][Full Text] [Related]
30. Methylation, a major mechanism of p16/CDKN2 gene inactivation in head and neck squamous carcinoma.
El-Naggar AK; Lai S; Clayman G; Lee JK; Luna MA; Goepfert H; Batsakis JG
Am J Pathol; 1997 Dec; 151(6):1767-74. PubMed ID: 9403727
[TBL] [Abstract][Full Text] [Related]
31. Associations of P16INK4a promoter hypermethylation with squamous intra-epithelial lesion, cervical cancer and their clinicopathological features: a meta-analysis.
Han YD; Wang XB; Cui NH; Zhang S; Wang C; Zheng F
Oncotarget; 2017 Jan; 8(1):1871-1883. PubMed ID: 27669738
[TBL] [Abstract][Full Text] [Related]
32. Promoter methylations of p16INK4a and p14ARF genes in early and advanced gastric cancer. Correlations of the modes of their occurrence with histologic type.
Tsujimoto H; Hagiwara A; Sugihara H; Hattori T; Yamagishi H
Pathol Res Pract; 2002; 198(12):785-94. PubMed ID: 12608655
[TBL] [Abstract][Full Text] [Related]
33.
Sailer V; Holmes EE; Gevensleben H; Goltz D; Dröge F; Franzen A; Dietrich J; Kristiansen G; Bootz F; Schröck A; Dietrich D
Clin Epigenetics; 2017; 9():12. PubMed ID: 28174607
[TBL] [Abstract][Full Text] [Related]
34. Mechanisms of p16INK4A inactivation in non small-cell lung cancers.
Gazzeri S; Gouyer V; Vour'ch C; Brambilla C; Brambilla E
Oncogene; 1998 Jan; 16(4):497-504. PubMed ID: 9484839
[TBL] [Abstract][Full Text] [Related]
35. The neuropeptide genes
Misawa K; Mima M; Imai A; Mochizuki D; Misawa Y; Endo S; Ishikawa R; Kanazawa T; Mineta H
Clin Epigenetics; 2018; 10():52. PubMed ID: 29682090
[TBL] [Abstract][Full Text] [Related]
36. p16INK4A adenovirus-mediated gene therapy for human head and neck squamous cell cancer.
Rocco JW; Li D; Liggett WH; Duan L; Saunders JK; Sidransky D; O'Malley BW
Clin Cancer Res; 1998 Jul; 4(7):1697-704. PubMed ID: 9676844
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of epigenetic inactivation of vascular endothelial growth factor receptors in head and neck squamous cell carcinoma.
Misawa Y; Misawa K; Kawasaki H; Imai A; Mochizuki D; Ishikawa R; Endo S; Mima M; Kanazawa T; Iwashita T; Mineta H
Tumour Biol; 2017 Jul; 39(7):1010428317711657. PubMed ID: 28718364
[TBL] [Abstract][Full Text] [Related]
38. Genome-wide DNA methylation profile identified a unique set of differentially methylated immune genes in oral squamous cell carcinoma patients in India.
Basu B; Chakraborty J; Chandra A; Katarkar A; Baldevbhai JRK; Dhar Chowdhury D; Ray JG; Chaudhuri K; Chatterjee R
Clin Epigenetics; 2017; 9():13. PubMed ID: 28174608
[TBL] [Abstract][Full Text] [Related]
39. Meta-analysis demonstrates no association between p16
Jiang Y; Yan F; Liang L; Wan Y; Liu J; Cheng W
Arch Gynecol Obstet; 2017 Mar; 295(3):697-704. PubMed ID: 28000027
[TBL] [Abstract][Full Text] [Related]
40. PTEN and p16 genes as epigenetic biomarkers in oral squamous cell carcinoma (OSCC): a study on south Indian population.
Sushma PS; Jamil K; Kumar PU; Satyanarayana U; Ramakrishna M; Triveni B
Tumour Biol; 2016 Jun; 37(6):7625-32. PubMed ID: 26687648
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
